TiGenix Starts Global Phase 3 Trial to Evaluate Cx601 as a Treatment for Crohn’s Fistulas
News
TiGenix has started a pivotal Phase 3 clinical trial of Cx601’s ability to treat a complication of Crohn’s disease known as complex perianal fistulas. Fistulas are sores between the end of the bowel ... Read more